23 results on '"Pinpathomrat, Nawamin"'
Search Results
2. Unveiling Post-COVID-19 Syndrome: Incidence, Biomarkers, and Clinical Phenotype in a Thai Population
3. Effectiveness of plant-based hand sanitizer incorporating Quercus infectoria gall extract
4. A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
5. Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
6. Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
7. Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP
8. Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants
9. Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases
10. T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
11. Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
12. Regulatory T Cells Decreased during Recovery from Mild COVID-19
13. Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
14. Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
15. Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
16. Impaired Neutralising Antibodies to SARS-CoV-2 Omicron BA.2 Variant and Preserved Cellular Immunogenicity Following Heterologous Prime-Boost Vaccination with an Inactivated Vaccine Followed by ChAdOx1-nCoV-19 in Patients with Systemic Autoimmune Rheumatic Diseases
17. Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
18. Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
19. Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
20. MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice
21. Identification of antigens presented by MHC for vaccines against tuberculosis
22. Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine
23. Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.